Prasugrel

BreastfeedingGeriatricPediatric
  • TRADE NAME: Effient (Lilly)
  • INDICATIONS: Acute coronary syndrome in patients who are to be managed with percutaneous coronary intervention
  • CLASS: Antiplatelet; thienopyridine
  • HALF-LIFE: 2–15 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Cangrelor, Clopidogrel, Conivaptan, Coumarins, Darunavir, Delavirdine, Diclofenac, Indinavir, Meloxicam, NSAIDs, Phenindione, Telithromycin, Voriconazole, Warfarin

PREGNANCY CATEGORY: B

Contra-indicated in patients with active pathological bleeding, prior transient ischemic attack or stroke.

BLEEDING RISK

See full prescribing information for complete boxed warning.

Our database has 43 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.


Page last updated 07/28/2020

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top